This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease: Improving Treatment While Working Toward…
In 2023, Aimed Alliance engaged in a wide variety of activities to protect and enhance the rights of health care…
On January 22, 2024, Aimed Alliance published two new resources on prescription drug affordability boards (PDABs). These boards, established at…
On January 5, 2024, the U.S. Food and Drug Administration (FDA) approved Florida’s Agency for Health Care Administration drug importation…
On January 5, 2024, Aimed Alliance submitted a comment on the Medicare Program Contract Year 2025 proposal. The comment expressed…
On January 8, 2024, Aimed Alliance submitted a comment to the Centers for Medicare and Medicaid Services (CMS) on the…
On January 3, 2024, CareTalk published an opinion piece authored by Michael C. Barnes, Counsel to Aimed Alliance. The article…
Governor Hochul has signed A.463A/S.2677! Next year plans will be required to include in an adverse determination letter: (1) instructions…
On December 22, 2023, the US District Court for the District of Columbia issued an Order clarifying the scope of…
On December 15, 2023 Aimed Alliance published a new resource titled Know Your Rights: Limited Formularies. Under the Patient Protection…